{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:39:15Z","timestamp":1762101555423},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jpba.2014.04.030","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T21:32:16Z","timestamp":1399066336000},"page":"107-112","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Quantitative determination of telavancin in pregnant baboon plasma by solid-phase extraction and LC\u2013ESI\u2013MS"],"prefix":"10.1016","volume":"98","author":[{"given":"Xiaoming","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana N.","family":"Nanovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.V.","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2014.04.030_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmwh.2008.02.001","article-title":"Methicillin-resistant Staphylococcus aureus infection in the obstetric setting","volume":"53","author":"Kriebs","year":"2008","journal-title":"J. Midwifery Women's Health"},{"key":"10.1016\/j.jpba.2014.04.030_bib0010","series-title":"Infectious Diseases of the Female Genital Tract","first-page":"3","article-title":"Clinical microbiology of the female genital tract. I*n","author":"Sweet","year":"2001"},{"key":"10.1016\/j.jpba.2014.04.030_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.AOG.0000175142.79347.12","article-title":"Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy","volume":"106","author":"Laibl","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jpba.2014.04.030_bib0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3201\/eid1106.040885","article-title":"Community-associated methicillan-resistant Staphylococcus aureus in hospital nursery and maternity units","volume":"11","author":"Bratu","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jpba.2014.04.030_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by Methicillin-Resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2014.04.030_bib0030","first-page":"127","article-title":"Telavancin (Vibativ), a new option for the treatment of gram-positive infections","volume":"36","author":"Plotkin","year":"2011","journal-title":"Drug Forecast."},{"key":"10.1016\/j.jpba.2014.04.030_bib0035","series-title":"Assessment Report: Vibativ","author":"European Medicines Agency","year":"2009"},{"key":"10.1016\/j.jpba.2014.04.030_bib0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1358\/dot.2009.45.3.1343792","article-title":"Telavancin: a new lipoglycopeptide for gram-positive infections","volume":"45","author":"Smith","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.jpba.2014.04.030_bib0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2014.04.030_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2007.03.005","article-title":"Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon","volume":"73","author":"Zharikova","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2014.04.030_bib0055","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijantimicag.2011.08.012","article-title":"Effect of telavancin on human intestinal microflora","volume":"38","author":"Rashid","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2014.04.030_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1592\/phco.30.1.35","article-title":"Lack of effect of moderate hepatic impairment on the pharmacokinetics of telavancin","volume":"30","author":"Goldberg","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpba.2014.04.030_bib0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.00875-07","article-title":"Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in viro activities of tealvancin and other antibiotics","volume":"52","author":"Gotfried","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2014.04.030_bib0070","series-title":"Guidance for Industry: Bio-analytical Method, Validation","author":"Food and Drug, Administration","year":"2013"},{"key":"10.1016\/j.jpba.2014.04.030_bib0075","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1208\/aapsj0901004","article-title":"Workshop\/conference report\u2014quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand biding assays","volume":"9","author":"Viswanathan","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2014.04.030_bib0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1570-0232(02)00244-1","article-title":"Linear regression for calibration lines revised: weighting schemes for bioanalytical methods","volume":"774","author":"Almdida","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.04.030_bib0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1570-0232(03)00068-0","article-title":"Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography-tandem mass spectrometry and oral bioavailabiity in rats","volume":"789","author":"Nobuhito","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.04.030_bib0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/rcm.246","article-title":"Rapid bioanalysis of vancomycin in serum and urine by high-performance liquid chromatography tandem mass spectrometry using on-line sample extraction and parallel analytical columns","volume":"15","author":"Cass","year":"2001","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2014.04.030_bib0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1387-3806(02)01023-0","article-title":"Quantification and confirmation of identity of analytes in various matrices with in-source collision-induced dissociation on a single quadrupole mass spectrometer","volume":"222","author":"Crellin","year":"2003","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2014.04.030_bib0100","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/jac\/dkn120","article-title":"Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)","volume":"61","author":"Barcia-Macay","year":"2008","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T11:29:09Z","timestamp":1538652549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708514002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":20,"alternative-id":["S0731708514002234"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2014.04.030","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative determination of telavancin in pregnant baboon plasma by solid-phase extraction and LC\u2013ESI\u2013MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2014.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}